We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
CAT No: B09063
CAS No: 342-10-9
Synonyms/Alias: KALLIDIN;Lys-Bradykinin;342-10-9;Lysyl-bradykinin;Lysylbradykinin;[Lys]bradykinin;Lys-BK;kallidin II;Bradykinin, Lysine;Bradykinin, N2-L-lysyl-;(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S)-1-[(2S)-1-[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid;UNII-0T8T4A440G;EINECS 206-438-0;(Lys)bradykinin;DTXSID40895018;0T8T4A440G;2-[[2-[[1-[2-[[2-[[2-[[1-[1-[2-(2,6-diaminohexanoylamino)-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid;N2-L-Lysylbradykinin;Lys Bradykinin;Lysyl Bradykinin;Lysine Bradykinin;Bradykinin, Lysyl;(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S)-1-[(2S)-1-[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-5-guanidino-pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-phenyl-propanoyl]amino]-3-hydroxy-propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenyl-propanoyl]amino]-5-guanidino-pentanoic acid;N2 L Lysylbradykinin;(2S)-2-(((2S)-2-(((2S)-1-((2S)-2-(((2S)-2-((2-(((2S)-1-((2S)-1-((2S)-2-(((2S)-2,6-diaminohexanoyl)amino)-5-(diaminomethylideneamino)pentanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carbonyl)amino)acetyl)amino)-3-phenylpropanoyl)amino)-3-hydroxypropanoyl)pyrrolidine-2-carbonyl)amino)-3-phenylpropanoyl)amino)-5-(diaminomethylideneamino)pentanoic acid;(2S)-2-(((2S)-2-(((2S)-1-((2S)-2-(((2S)-2-((2-(((2S)-1-((2S)-1-((2S)-2-(((2S)-2,6-diaminohexanoyl)amino)-5-guanidino-pentanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carbonyl)amino)acetyl)amino)-3-phenyl-propanoyl)amino)-3-hydroxy-propanoyl)pyrrolidine-2-carbonyl)amino)-3-phenyl-propanoyl)amino)-5-guanidino-pentanoic acid;KALLIDIN [MI];KALLIDIN-10;Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg;GTPL650;SCHEMBL150645;CHEBI:6102;FYSKZKQBTVLYEQ-FSLKYBNLSA-N;DTXCID501324577;AKOS024457492;HY-103293;CS-0027229;C01505;Q2398786;206-438-0;L-ARGININE, L-LYSYL-L-ARGINYL-L-PROLYL-L-PROLYLGLYCYL-L-PHENYLALANYL-L-SERYL-L-PROLYL-L-PHENYLALANYL-;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C56H85N17O12 |
M.W/Mr. | 1188.4 |
Sequence | One Letter Code:KRPPGFSPFR Three Letter Code:H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH |
Source# | Synthetic |
InChI | InChI=1S/C56H85N17O12/c57-24-8-7-18-36(58)46(76)67-37(19-9-25-63-55(59)60)51(81)73-29-13-23-44(73)53(83)72-28-11-21-42(72)49(79)65-32-45(75)66-39(30-34-14-3-1-4-15-34)47(77)70-41(33-74)52(82)71-27-12-22-43(71)50(80)69-40(31-35-16-5-2-6-17-35)48(78)68-38(54(84)85)20-10-26-64-56(61)62/h1-6,14-17,36-44,74H,7-13,18-33,57-58H2,(H,65,79)(H,66,75)(H,67,76)(H,68,78)(H,69,80)(H,70,77)(H,84,85)(H4,59,60,63)(H4,61,62,64)/t36-,37-,38-,39-,40-,41-,42-,43-,44-/m0/s1 |
InChI Key | FYSKZKQBTVLYEQ-FSLKYBNLSA-N |
1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com